295 related articles for article (PubMed ID: 15531726)
21. Crosstalk between androgen receptor and epidermal growth factor receptor-signalling pathways: a molecular switch for epithelial cell differentiation.
Léotoing L; Manin M; Monté D; Baron S; Communal Y; Lours C; Veyssière G; Morel L; Beaudoin C
J Mol Endocrinol; 2007 Aug; 39(2):151-62. PubMed ID: 17693613
[TBL] [Abstract][Full Text] [Related]
22. Expression of leukemia inhibitory factor and leukemia inhibitory factor receptor in the canine pituitary gland and corticotrope adenomas.
Hanson JM; Mol JA; Meij BP
Domest Anim Endocrinol; 2010 May; 38(4):260-71. PubMed ID: 20036483
[TBL] [Abstract][Full Text] [Related]
23. Analysis of the epidermal growth factor receptor specific transcriptome: effect of receptor expression level and an activating mutation.
Pedersen MW; Pedersen N; Damstrup L; Villingshøj M; Sønder SU; Rieneck K; Bovin LF; Spang-Thomsen M; Poulsen HS
J Cell Biochem; 2005 Oct; 96(2):412-27. PubMed ID: 16075456
[TBL] [Abstract][Full Text] [Related]
24. The expression of the antiproliferative gene ZAC is lost or highly reduced in nonfunctioning pituitary adenomas.
Pagotto U; Arzberger T; Theodoropoulou M; Grübler Y; Pantaloni C; Saeger W; Losa M; Journot L; Stalla GK; Spengler D
Cancer Res; 2000 Dec; 60(24):6794-9. PubMed ID: 11156367
[TBL] [Abstract][Full Text] [Related]
25. Y-box-binding protein 1 confers EGF independence to human mammary epithelial cells.
Berquin IM; Pang B; Dziubinski ML; Scott LM; Chen YQ; Nolan GP; Ethier SP
Oncogene; 2005 Apr; 24(19):3177-86. PubMed ID: 15735691
[TBL] [Abstract][Full Text] [Related]
26. p75 and TrkC neurotrophin receptors demonstrate a different immunoreactivity profile in comparison to TrkA and TrkB receptors in human normal pituitary gland and adenomas.
Assimakopoulou M; Zolota V; Chondrogianni C; Gatzounis G; Varakis J
Neuroendocrinology; 2008; 88(2):127-34. PubMed ID: 18319596
[TBL] [Abstract][Full Text] [Related]
27. Heparin-binding epidermal growth factor-like growth factor isoforms and epidermal growth factor receptor/ErbB1 expression in bladder cancer and their relation to clinical outcome.
Kramer C; Klasmeyer K; Bojar H; Schulz WA; Ackermann R; Grimm MO
Cancer; 2007 May; 109(10):2016-24. PubMed ID: 17394193
[TBL] [Abstract][Full Text] [Related]
28. Expression of GATA-2 in human pituitary adenomas.
Umeoka K; Sanno N; Osamura RY; Teramoto A
Mod Pathol; 2002 Jan; 15(1):11-7. PubMed ID: 11796836
[TBL] [Abstract][Full Text] [Related]
29. Overexpression of epidermal growth factor and hepatocyte growth factor receptors in a proportion of gastrinomas correlates with aggressive growth and lower curability.
Peghini PL; Iwamoto M; Raffeld M; Chen YJ; Goebel SU; Serrano J; Jensen RT
Clin Cancer Res; 2002 Jul; 8(7):2273-85. PubMed ID: 12114431
[TBL] [Abstract][Full Text] [Related]
30. "Silent"corticotropinoma.
Pawlikowski M; Kunert-Radek J; Radek M
Neuro Endocrinol Lett; 2008 Jun; 29(3):347-50. PubMed ID: 18580839
[TBL] [Abstract][Full Text] [Related]
31. Epidermal growth factor receptor expression and activation in nonseminomatous germ cell tumors.
Moroni M; Veronese S; Schiavo R; Carminati O; Sorensen BS; Gambacorta M; Siena S
Clin Cancer Res; 2001 Sep; 7(9):2770-5. PubMed ID: 11555591
[TBL] [Abstract][Full Text] [Related]
32. Protein kinase C zeta mediates epidermal growth factor-induced growth of head and neck tumor cells by regulating mitogen-activated protein kinase.
Cohen EE; Lingen MW; Zhu B; Zhu H; Straza MW; Pierce C; Martin LE; Rosner MR
Cancer Res; 2006 Jun; 66(12):6296-303. PubMed ID: 16778206
[TBL] [Abstract][Full Text] [Related]
33. The expression of ghrelin in somatotroph and other types of pituitary adenomas.
Wasko R; Jaskula M; Kotwicka M; Andrusiewicz M; Jankowska A; Liebert W; Sowinski J
Neuro Endocrinol Lett; 2008 Dec; 29(6):929-38. PubMed ID: 19112387
[TBL] [Abstract][Full Text] [Related]
34. Growth hormone receptor mRNA expression in non-functioning and somatotroph pituitary adenomas: implications for growth hormone substitution therapy?
Beuschlein F; Hancke K; Petrick M; Göbel H; Honegger J; Reincke M
Exp Clin Endocrinol Diabetes; 2005 Apr; 113(4):214-8. PubMed ID: 15891957
[TBL] [Abstract][Full Text] [Related]
35. Immunohistochemical analysis of p27 (Kip1) in human pituitary glands and in various types of pituitary adenomas.
Komatsubara K; Tahara S; Umeoka K; Sanno N; Teramoto A; Osamura RY
Endocr Pathol; 2001; 12(2):181-8. PubMed ID: 11579684
[TBL] [Abstract][Full Text] [Related]
36. Expression of interleukin-6, interleukin-6 receptor (gp80), and the receptor's signal-transducing subunit (gp130) in human normal pituitary glands and pituitary adenomas.
Kurotani R; Yasuda M; Oyama K; Egashira N; Sugaya M; Teramoto A; Osamura RY
Mod Pathol; 2001 Aug; 14(8):791-7. PubMed ID: 11504839
[TBL] [Abstract][Full Text] [Related]
37. Expression of genes related to corticotropin production and glucocorticoid feedback in corticotroph adenomas of dogs with Cushing's disease.
Teshima T; Hara Y; Takekoshi S; Teramoto A; Osamura RY; Tagawa M
Domest Anim Endocrinol; 2009 Jan; 36(1):3-12. PubMed ID: 18818046
[TBL] [Abstract][Full Text] [Related]
38. Expression of receptor tyrosine kinases epidermal growth factor receptor and HER-2/neu in synovial sarcoma.
Thomas DG; Giordano TJ; Sanders D; Biermann S; Sondak VK; Trent JC; Yu D; Pollock RE; Baker L
Cancer; 2005 Feb; 103(4):830-8. PubMed ID: 15641030
[TBL] [Abstract][Full Text] [Related]
39. Expression of epidermal growth factor (EGF), its receptor, and related oncoprotein (erbB-2) in human pituitary tumors and response to EGF in vitro.
Chaidarun SS; Eggo MC; Sheppard MC; Stewart PM
Endocrinology; 1994 Nov; 135(5):2012-21. PubMed ID: 7956924
[TBL] [Abstract][Full Text] [Related]
40. Activation of the EGFR gene target EphA2 inhibits epidermal growth factor-induced cancer cell motility.
Larsen AB; Pedersen MW; Stockhausen MT; Grandal MV; van Deurs B; Poulsen HS
Mol Cancer Res; 2007 Mar; 5(3):283-93. PubMed ID: 17374733
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
